Earnings results for IQVIA (NYSE:IQV)
IQVIA Holdings, Inc. is estimated to report earnings on 10/19/2021. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 6 analysts’ forecasts, the consensus EPS forecast for the quarter is $1.99. The reported EPS for the same quarter last year was $1.5.
IQVIA last announced its earnings data on July 27th, 2021. The medical research company reported $2.13 earnings per share for the quarter, topping analysts’ consensus estimates of $2.07 by $0.06. The firm had revenue of $3.44 billion for the quarter, compared to the consensus estimate of $3.27 billion. Its revenue for the quarter was up 36.4% compared to the same quarter last year. IQVIA has generated $6.03 earnings per share over the last year ($3.12 diluted earnings per share) and currently has a price-to-earnings ratio of 77.6. Earnings for IQVIA are expected to grow by 13.80% in the coming year, from $8.26 to $9.40 per share. IQVIA has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Tuesday, October 19th, 2021 based off prior year’s report dates.
Analyst Opinion on IQVIA (NYSE:IQV)
According to the issued ratings of 16 analysts in the last year, the consensus rating for IQVIA stock is Buy based on the current 1 hold rating and 15 buy ratings for IQV. The average twelve-month price target for IQVIA is $262.18 with a high price target of $290.00 and a low price target of $224.00.
on IQV’s analyst rating history
IQVIA has received a consensus rating of Buy. The company’s average rating score is 2.94, and is based on 15 buy ratings, 1 hold rating, and no sell ratings. According to analysts’ consensus price target of $262.18, IQVIA has a forecasted upside of 8.2% from its current price of $242.23. IQVIA has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.
Dividend Strength: IQVIA (NYSE:IQV)
IQVIA does not currently pay a dividend. IQVIA does not have a long track record of dividend growth.
Insiders buying/selling: IQVIA (NYSE:IQV)
In the past three months, IQVIA insiders have not sold or bought any company stock. Only 1.10% of the stock of IQVIA is held by insiders. 87.01% of the stock of IQVIA is held by institutions. High institutional ownership can be a signal of strong market trust in this company.
Earnings and Valuation of IQVIA (NYSE:IQV
Earnings for IQVIA are expected to grow by 13.80% in the coming year, from $8.26 to $9.40 per share. The P/E ratio of IQVIA is 77.64, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 14.68. The P/E ratio of IQVIA is 77.64, which means that it is trading at a more expensive P/E ratio than the Business Services sector average P/E ratio of about 26.29. IQVIA has a PEG Ratio of 1.85. PEG Ratios above 1 indicate that a company could be overvalued. IQVIA has a P/B Ratio of 7.39. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.
More latest stories: here